Promoter DNA methylation, an epigenetic modification is notably seen to contribute to the development of leukemia as confirmed in case of FHIT gene in various forms of cancers [16–18] and in particular ALL [19, 20]. This evidence concerns the gene FHIT and acute lymphoblastic leukemia.